Skip to main content

Cormorant Asset Management, LP

Position in PCVX — Vaxcyte, Inc.

CIK 1583977 BOSTON, MA

Position in PCVX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,906,500
-$2,904,500 QoQ
Shares Held
50,000
-50.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#118
of 329 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCVX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. PCVX ranks #44 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCVX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,906,500 50,000
2026-03-31 $5,811,000 100,000
2025-12-31 $5,767,500 125,000
2025-09-30 $6,303,500 175,000
2025-06-30 $5,689,250 175,000
2025-03-31 $6,608,000 175,000
2024-12-31 $34,790,500 425,000
2024-09-30 $114,270,000 1,000,000
2024-06-30 $83,061,000 1,100,000
2024-03-31 $46,792,350 685,000
2023-12-31 $41,762,000 665,000
2023-09-30 $33,901,700 665,000
2023-06-30 $33,210,100 665,000
2023-03-31 $10,307,000 275,000
2022-12-31 $15,583,750 325,000